Hims & Hers Health, Inc.
For the period ended Mar 31, 2026. Filed May 11, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2026 · Filed May 11, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 5. Other Information
(a) Amendment to Revolving Credit and Guaranty Agreement.
On May 7, 2026, we entered into an amendment to our Revolving Credit and Guaranty Agreement with certain lenders and JPMorgan Chase Bank, N.A., as administrative and collateral agent. The amendment modifies the definition of the numerator used in the calculation of total leverage ratio in the Revolving Credit and Guaranty Agreement by expanding the definition of “cash equivalents” to include investments made in accordance with the investment policy adopted by our Board of Directors. The total leverage ratio that we are required to maintain did not change The foregoing summary is qualified by reference to the complete text of the amendment, which is attached as an exhibit to this Quarterly Report on Form 10-Q and incorporated by reference herein.
(c) Insider trading arrangements.
During the fiscal quarter ended March 31, 2026, none of our directors or officers adopted orterminated a “Rule 10b5-1 trading arrangement” or “non-Rule 10b5-1 trading arrangement,” as those terms are defined in Item 408 of Regulation S-K.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.